Global Ketorolac Market Survey and Trend Research 2018

May 2018 | 88 pages | ID: G6AD6151902EN
99Strategy

Abstracts

SUMMARY

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Allergan, DeepCare Health, Cadila, FDC, Gufic Chem, Gufic Chem, Ranbaxy, Adley Formulation, Neon Laboratories, Sun Pharmaceutical Industries, Cipla, Dallas Pharmaceuticals, Nicholas Piramal India, AHPL etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Ketorolac Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 KETOROLAC MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 Key Companies List
4.1 Allergan (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 DeepCare Health (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Cadila (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 FDC (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Gufic Chem (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Gufic Chem (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Ranbaxy (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Adley Formulation (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Neon Laboratories (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Sun Pharmaceutical Industries (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Cipla (Company Overview, Sales Data etc.)
4.12 Dallas Pharmaceuticals (Company Overview, Sales Data etc.)
4.13 Nicholas Piramal India (Company Overview, Sales Data etc.)
4.14 AHPL (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Ketorolac Market 2012-2017, by Type, in USD Million
Table Global Ketorolac Market 2012-2017, by Type, in Volume
Table Global Ketorolac Market Forecast 2018-2023, by Type, in USD Million
Table Global Ketorolac Market Forecast 2018-2023, by Type, in Volume
Table Allergan Overview List
Table Ketorolac Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table DeepCare Health Overview List
Table Ketorolac Business Operation of DeepCare Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cadila Overview List
Table Ketorolac Business Operation of Cadila (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table FDC Overview List
Table Ketorolac Business Operation of FDC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gufic Chem Overview List
Table Ketorolac Business Operation of Gufic Chem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gufic Chem Overview List
Table Ketorolac Business Operation of Gufic Chem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ranbaxy Overview List
Table Ketorolac Business Operation of Ranbaxy (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Adley Formulation Overview List
Table Ketorolac Business Operation of Adley Formulation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Neon Laboratories Overview List
Table Ketorolac Business Operation of Neon Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharmaceutical Industries Overview List
Table Ketorolac Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Ketorolac Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dallas Pharmaceuticals Overview List
Table Ketorolac Business Operation of Dallas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nicholas Piramal India Overview List
Table Ketorolac Business Operation of Nicholas Piramal India (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AHPL Overview List
Table Ketorolac Business Operation of AHPL (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Ketorolac Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Ketorolac Sales Revenue Share, by Companies, in USD Million
Table Global Ketorolac Sales Volume 2012-2017, by Companies, in Volume
Table Global Ketorolac Sales Revenue Share, by Companies in 2017, in Volume
Table Ketorolac Demand 2012-2017, by Application, in USD Million
Table Ketorolac Demand 2012-2017, by Application, in Volume
Table Ketorolac Demand Forecast 2018-2023, by Application, in USD Million
Table Ketorolac Demand Forecast 2018-2023, by Application, in Volume
Table Global Ketorolac Market 2012-2017, by Region, in USD Million
Table Global Ketorolac Market 2012-2017, by Region, in Volume
Table Ketorolac Market Forecast 2018-2023, by Region, in USD Million
Table Ketorolac Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Ketorolac Industry Chain Structure
Figure Global Ketorolac Market Growth 2012-2017, by Type, in USD Million
Figure Global Ketorolac Market Growth 2012-2017, by Type, in Volume
Figure Global Ketorolac Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Ketorolac Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region